Literature DB >> 29302086

Reassessment of Health-System Capacity for Experiential Education Requirements.

Matthew J Gibson1, Lynette R Bradley-Baker2, Colleen G Bush3, Steven P Nelson4.   

Abstract

Objective. To provide an update to the 2007 ASHP-AACP survey by examining the current capacity of hospitals/health systems' ability to conduct experiential education for doctor of pharmacy students. Methods. Pharmacists identified as pharmacy directors were sent an invitation to participate in an online survey tool. The survey tool asked IPPE- and APPE-specific questions, the nature of support provided by colleges/schools of pharmacy, the types of experiences available for students, and the factors influencing the quality, value, and challenges of experiential education. Results. Four hundred sixty five of the 2,911 surveys sent were completed yielding a response rate of 16%. Respectively, 45.1% and 28.5% of respondents believe that the capacity for APPE and IPPE will increase in the next five years. Overall, respondents believe that students receive a high-quality experiential education (91.4%). Conclusion. The results of this survey provide insight to the capacity, benefits and challenges of experiential education from the perspective of hospitals/health systems.

Entities:  

Keywords:  APPE; Experiential education; IPPE

Mesh:

Year:  2017        PMID: 29302086      PMCID: PMC5738944          DOI: 10.5688/ajpe6014

Source DB:  PubMed          Journal:  Am J Pharm Educ        ISSN: 0002-9459            Impact factor:   2.047


  15 in total

Review 1.  Value of the student pharmacist to experiential practice sites: a review of the literature.

Authors:  Tracey L Mersfelder; Michael J Bouthillier
Journal:  Ann Pharmacother       Date:  2012-04-03       Impact factor: 3.154

2.  Capacity of hospitals to partner with academia to meet experiential education requirements for pharmacy students.

Authors:  Douglas J Scheckelhoff; Colleen G Bush; Arlene A Flynn; George E MacKinnon; Charles E Myers; Abby A Kahaleh; Katherine K Knapp; Joy L Meier; Terrence L Schwinghammer; Steven L Sheaffer; Brent J Thompson; Charles F McCluskey
Journal:  Am J Health Syst Pharm       Date:  2008-11-01       Impact factor: 2.637

3.  Complete-block scheduling for advanced pharmacy practice experiences.

Authors:  Randy C Hatton; Kristin W Weitzel
Journal:  Am J Health Syst Pharm       Date:  2013-12-01       Impact factor: 2.637

4.  Developing and implementing an Academy of Preceptors.

Authors:  Cynthia J Boyle; Jill A Morgan; Cherokee Layson-Wolf; Magaly Rodriguez de Bittner
Journal:  Am J Pharm Educ       Date:  2009-04-07       Impact factor: 2.047

5.  National trends in IPPE programs at US schools of pharmacy from 2008-2013.

Authors:  Patricia S Devine; Patricia L Darbishire
Journal:  Am J Pharm Educ       Date:  2015-04-25       Impact factor: 2.047

6.  A qualitative analysis of common concerns about challenges facing pharmacy experiential education programs.

Authors:  Jennifer Danielson; Karen Craddick; Dayl Eccles; Abigail Kwasnik; Teresa A O'Sullivan
Journal:  Am J Pharm Educ       Date:  2015-02-17       Impact factor: 2.047

7.  Cost savings associated with pharmacy student interventions during APPEs.

Authors:  Brian M Shepler
Journal:  Am J Pharm Educ       Date:  2014-05-15       Impact factor: 2.047

8.  Status of pharmacy practice experience education programs.

Authors:  Jennifer Danielson; Dayl Eccles; Abigail Kwasnik; Karen Craddick; Andrew K Heinz; Arthur F Harralson
Journal:  Am J Pharm Educ       Date:  2014-05-15       Impact factor: 2.047

9.  Potential cost avoidance of pharmacy students' patient care activities during advanced pharmacy practice experiences.

Authors:  Adam B Woolley; Charles A Berds; Roger A Edwards; Debra Copeland; Margarita V DiVall
Journal:  Am J Pharm Educ       Date:  2013-10-14       Impact factor: 2.047

10.  Advancing the pharmacy practice model in a community teaching hospital by expanding student rotations.

Authors:  Osmel Delgado; William P Kernan; Scott J Knoer
Journal:  Am J Health Syst Pharm       Date:  2014-11-01       Impact factor: 2.637

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.